Zdrowie i gospodarka · 05/02/2018

FDA Classifies Percutaneous Nerve Stimulator for Substance Use Disorders into Class II with Special Controls

The FDA has classified the percutaneous nerve stimulator for substance use disorders into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.